Búsqueda de Publicación - Prisma - Unidad de Bibliometría

Publicaciones en la fuente LIVER INTERNATIONAL

Tipo Año Título Fuente
Artículo2024Development and validation of an image biomarker to identify metabolic dysfunction associated steatohepatitis: MR–MASH scoreLIVER INTERNATIONAL
Revisión2024Novel insights into metabolic-associated steatotic liver disease preclinical modelsLIVER INTERNATIONAL
Artículo2024Rituximab is a safe and effective alternative treatment for patients with autoimmune hepatitis: results from the ColHai registryLIVER INTERNATIONAL
Artículo2024The role of HBIG in real life for patients undergoing liver transplantation due to HDV-related cirrhosisLIVER INTERNATIONAL
Artículo2023Alcohol-related liver disease phenotype impacts survival after an acute variceal bleeding episode.LIVER INTERNATIONAL
Artículo2023Prognostic value of non-invasive scores based on liver stiffness measurement, spleen diameter and platelets in HIV-infected patients.LIVER INTERNATIONAL
Artículo2023Role of EpCAM+ CD133+ extracellular vesicles in steatosis to steatohepatitis transition in NAFLD.LIVER INTERNATIONAL
Artículo2022A cholestatic pattern predicts major liver-related outcomes in patients with nonalcoholic fatty liver disease.LIVER INTERNATIONAL
Artículo2022Long non-coding RNA H19 as a biomarker for hepatocellular carcinomaLIVER INTERNATIONAL
Artículo2022Prevalence estimation of significant fibrosis because of NASH in Spain combining transient elastography and histologyLIVER INTERNATIONAL
Artículo2021Definite and indeterminate nonalcoholic steatohepatitis share similar clinical features and prognosis: a longitudinal study of 1893 biopsy-proven nonalcoholic fatty liver disease subjectsLIVER INTERNATIONAL
Artículo2021Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis in five European countries in 2018: A cost-of-illness analysisLIVER INTERNATIONAL
Artículo2021HCV microelimination strategies: an interventional study in diagnosed patients without access to the systemLIVER INTERNATIONAL
Artículo2021Management of NAFLD patients with advanced fibrosisLIVER INTERNATIONAL
Artículo2020Bacterial antigen translocation and age as BMI-independent contributing factors on systemic inflammation in NAFLD patientsLIVER INTERNATIONAL
Artículo2020Oral glutamine challenge is a marker of altered ammonia metabolism and predicts the risk of hepatic encephalopathyLIVER INTERNATIONAL
Revisión2020The role of nutrition in non-alcoholic fatty liver disease: Pathophysiology and managementLIVER INTERNATIONAL
Artículo2019A genome-wide association study on low susceptibility to hepatitis C virus infection (GEHEP012 study)LIVER INTERNATIONAL
Artículo2018Diagnostic accuracy of SCCA and SCCA-IgM for hepatocellular carcinoma: A meta-analysisLIVER INTERNATIONAL
Artículo2017High efficacy of Sofosbuvir plus Simeprevir in a large cohort of Spanish cirrhotic patients infected with genotypes 1 and 4LIVER INTERNATIONAL
Artículo2017Lactulose reduces bacterial DNA translocation, which worsens neurocognitive shape in cirrhotic patients with minimal hepatic encephalopathyLIVER INTERNATIONAL
Artículo2015Safety and efficacy of triple therapy with peginterferon, ribavirin and boceprevir within an early access programme in Spanish patients with hepatitis C genotype 1 with severe fibrosis: SVRw12 analysisLIVER INTERNATIONAL
Artículo2015The value of serum aspartate aminotransferase and gamma-glutamyl transpetidase as biomarkers in hepatotoxicityLIVER INTERNATIONAL
Artículo2014A polymorphism linked to RRAS, SCAF1, IRF3 and BCL2L12 genes is associated with cirrhosis in hepatitis C virus carriersLIVER INTERNATIONAL
Artículo2014Hepatitis C virus-specific cellular immune responses in sustained virological responders with viral persistence in peripheral blood mononuclear cellsLIVER INTERNATIONAL
Artículo2014Identification of candidate biomarkers for hepatocellular carcinoma in plasma of HCV-infected cirrhotic patients by 2-D DIGELIVER INTERNATIONAL
Letter2012Liver stiffness correlates with Child-Pugh-Turcotte and MELD scores in HIV/hepatitis C virus-coinfected patients with cirrhosisLIVER INTERNATIONAL
Artículo2011Brain biomolecules oxidation in portacaval-shunted ratsLIVER INTERNATIONAL
Revisión2011Genes and hepatitis C: susceptibility, fibrosis progression and response to treatmentLIVER INTERNATIONAL
Editorial2011Insulin resistance and sustained virological response in hepatitis C: from bench to bedsideLIVER INTERNATIONAL
Revisión2009Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelinesLIVER INTERNATIONAL
Artículo2008High prevalence of hepatitis C virus infection among noninjecting drug users: association with sharing the inhalation implements of crackLIVER INTERNATIONAL
Artículo2005Altered protein expression and protein nitration pattern during D-galactosamine-induced cell death in human hepatocytes: a proteomic analysisLIVER INTERNATIONAL
Artículo2004Role of NF-κB activation and nitric oxide expression during PGE1 protection against D-galactosamine-induced cell death in cultured rat hepatocytesLIVER INTERNATIONAL